menu
    • menu
    [{"orgOrder":0,"company":"Helex","sponsor":"pi Ventures | Bluehill Capital | SOSV","pharmaFlowCategory":"D","therapeuticArea":"Genetic Disease","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2025","type":"Acquisition","leadProduct":"Undisclosed","moa":"PKD1","graph1":"Genetic Disease","graph2":"Preclinical","graph3":"Helex","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helex \/ pi Ventures | Bluehill Capital | SOSV","highestDevelopmentStatusID":"4","companyTruncated":"Helex \/ pi Ventures | Bluehill Capital | SOSV"}]

    Find Clinical Drug Pipeline Developments & Deals by Helex

    Menu

    Helex

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Helex

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Helex

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Genetic Disease

                            Study Phase : Preclinical

                            Sponsor : pi Ventures | Bluehill Capital | SOSV

                            Deal Size : $3.5 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Helex Raises $3.5M to Advance Non-Viral Gene Therapies for Kidney Diseases

                            Details : Through the acquisition of an undisclosed cell & gene therapy targeting PKD1, the deal aims to advance treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD).

                            Product Name : Undisclosed

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            October 30, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Genetic Disease

                            Highest Development Status : Preclinical

                            Sponsor : pi Ventures | Bluehill Capital | SOSV

                            Deal Size : $3.5 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth